MESOTIP: Phase II multicenter randomized trial evaluating the association of PIPAC and systemic chemotherapy vs. systemic chemotherapy alone as 1st-line treatment of malignant peritoneal mesothelioma

DOI: 10.1515/pp-2019-0010

Keywords: conversion to respectability, front line, intraperitoneal chemotherapy, malignant peritoneal mesothelioma, Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC)

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text